Covaxin booster dose works against Omicron and Delta variants, claims Bharat Biotech

Bharat Biotech has made a big claim about the indigenous vaccine Covaccine amidst increasing cases of corona virus in India. Bharat Biotech said on Tuesday that the booster dose of Covaxin neutralizes the Omicron and Delta variants of the corona virus. The company has made this claim after the initial results of the ongoing research on booster doses.

Bharat Biotech said, we found that 100 percent of the test serum samples neutralized the Delta variant and more than 90 percent of the test serum samples neutralized the Omicron variant. Bharat Biotech says that during the trial, antibodies in people who took booster doses of the vaccine increased by 5 times compared to those who took two doses.

COVAXIN® (BBV152) Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2#bbv152 #COVAXIN #BharatBiotech #COVID19Vaccine #omicron #deltavariant #SARS_CoV_2 #covaxinapproval #boosterdose #pandemic pic.twitter.com/0IgFmm13rS

— BharatBiotech (@BharatBiotech) January 12, 2022

The company said that there was an increase in CD4 and CD8 cells in people taking the booster dose. These are the cells that provide long-term protection to any person against corona. Earlier, the company had found the performance of Covaccine to be better against the concern variants Alpha, Beta, Delta, Zeta and Kappa of Kovid in studies.

The company said that the data that has come out during the test is evidence that covaccine is a great option to protect against the increasing risk of corona. Along with this, the company has also claimed that no side effects have been seen with the booster dose of Covaccine. Along with this, the company has also claimed that no side effects have been seen with the booster dose of Covaccine.